| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 16 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-06 |
4 |
B |
$15.45 |
$188,490 |
I/I |
12,200 |
4,067 |
2.1 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-31 |
4 |
S |
$1.90 |
$189,207 |
I/I |
(99,382) |
11,106,255 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-05-22 |
4 |
A |
$19.06 |
$190,600 |
I/I |
10,000 |
2,053,723 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-06-14 |
4 |
B |
$13.67 |
$191,831 |
I/I |
14,033 |
12,102,158 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-14 |
4 |
B |
$19.19 |
$191,900 |
I/I |
10,000 |
1,474,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-14 |
4 |
A |
$12.86 |
$192,900 |
I/I |
15,000 |
1,814,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-12-31 |
4 |
B |
$19.37 |
$193,700 |
I/I |
10,000 |
10,726,589 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-10 |
4 |
B |
$4.34 |
$196,281 |
I/I |
45,226 |
18,563,916 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-04-17 |
4 |
B |
$21.85 |
$196,650 |
I/I |
9,000 |
10,772,173 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-12 |
4 |
B |
$9.92 |
$198,400 |
I/I |
20,000 |
14,774,942 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-11 |
4 |
B |
$9.99 |
$199,800 |
I/I |
20,000 |
14,754,942 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-05-15 |
4 |
B |
$20.00 |
$200,000 |
I/I |
10,000 |
13,340,028 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-11-05 |
4 |
B |
$16.81 |
$200,022 |
I/I |
11,899 |
10,890,669 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-06-13 |
4 |
S |
$105.75 |
$200,073 |
I/I |
(1,892) |
27,110 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-05-30 |
4 |
A |
$18.77 |
$200,839 |
I/I |
10,700 |
2,097,023 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-04 |
4 |
S |
$1.99 |
$203,153 |
I/I |
(102,000) |
11,004,255 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-27 |
4 |
B |
$2.05 |
$204,580 |
I/I |
100,000 |
431,811 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-15 |
4 |
B |
$20.80 |
$208,000 |
I/I |
10,000 |
1,484,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-21 |
4 |
A |
$10.44 |
$208,800 |
I/I |
20,000 |
1,924,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-24 |
4 |
A |
$10.53 |
$210,600 |
I/I |
20,000 |
1,944,423 |
0 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-08-17 |
4 |
B |
$7.18 |
$211,447 |
I/I |
29,440 |
5,985,953 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-16 |
4 |
B |
$21.18 |
$211,800 |
I/I |
10,000 |
1,494,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-20 |
4 |
A |
$10.88 |
$217,600 |
I/I |
20,000 |
1,904,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-06-13 |
4 |
B |
$13.70 |
$218,748 |
I/I |
15,967 |
12,088,125 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-20 |
4 |
S |
$1.90 |
$219,435 |
D/D |
(115,492) |
6,803,900 |
0 |
- |
|
634 Records found
|
|
Page 16 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
